Enhanced erythropoiesis and iron metabolism

  • US 10,894,774 B2
  • Filed: 04/27/2017
  • Issued: 01/19/2021
  • Est. Priority Date: 06/06/2003
  • Status: Active Grant
First Claim
Patent Images

1. A method for decreasing hepcidin in a subject in need thereof, the method comprising administering to the subject an effective amount of a heterocyclic carboxamide compound that stabilizes the alpha subunit of hypoxia-inducible factor (HIFα

  • ), thereby decreasing hepcidin in the subject, wherein the heterocyclic carboxamide compound is a compound of Formula 1;

View all claims

    Thank you for your feedback